Title: When Startups Mirror the Uncertainty of Fertility Treatments
Last week, I found myself reflecting on the unpredictability that permeates both my professional worlds—IVF and angel investing. It was during a consultation with a couple who had experienced another failed IVF cycle. Their eyes, filled with a complex mix of despair and determination, reminded me of the startup founders I’ve mentored who face setbacks with similar emotional turmoil. It hit me that both arenas, though vastly different, are united by a shared theme: uncertainty.
In the realm of IVF, uncertainty is an unwelcome companion. Each cycle is a gamble, where precise science meets the unpredictable nature of biology. I’ve sat across many hopeful couples, like the one last week, delivering both good and bad news. The emotional rollercoaster that IVF patients endure is something I strive to navigate with them, offering not just medical expertise but also emotional support. This is a theme I explore in depth in my piece on why fertility treatments demand more than just medical expertise.
In angel investing, the stakes are different but equally uncertain. I recall a founder I backed who was full of enthusiasm and vision, yet the market didn’t respond as anticipated. Just like the couple in my clinic, he faced a moment of reckoning. Was the idea flawed? Was it bad timing? Or was it just a temporary setback? These are questions that any entrepreneur must grapple with, much like the couples questioning their fertility journey.
Many people believe that technology and data can eliminate uncertainty. In startups, there’s a prevailing myth that a robust business plan and market analysis can predict success. Similarly, in IVF, patients often cling to the belief that advanced medical technology can guarantee a healthy pregnancy. But in reality, both journeys are fraught with variables beyond our control.
The myth of certainty is comforting but ultimately misleading. In the startup world, I’ve seen business plans that appear bulletproof on paper crumble in the face of real-world complexities. Markets shift, consumer behaviors change, and unexpected competitors emerge. No amount of data can account for these dynamic factors. Likewise, in IVF, while we rely heavily on data—hormone levels, egg quality, embryo grading—the outcome remains uncertain. The science behind conception is precise, yet the journey is anything but predictable.
In my experience, the real challenge is not the uncertainty itself but how we respond to it. For IVF patients, this means building resilience and finding ways to cope with the emotional and financial stress. I often advise couples to engage in what I call “daily joy practices,” simple rituals that provide emotional stability. It might be a morning walk, a quiet moment of meditation, or even writing in a journal. These practices create a reservoir of joy that couples can draw upon during the tough times. It’s about finding a balance between hope and acceptance.
For startup founders, embracing uncertainty involves a different kind of resilience. It requires a willingness to pivot, to adapt strategies when initial plans falter. I’ve often seen that the most successful entrepreneurs are those who view setbacks not as failures but as opportunities to learn and innovate. This mindset is crucial in both domains. In fact, I delve into this topic in my post on the unseen connection between risk in startups and IVF treatments.
One might ask, why not just eliminate uncertainty altogether? Why not wait until all the variables align perfectly? The truth is, such a moment rarely exists. In IVF, waiting for the perfect cycle can mean losing valuable time, especially as age significantly impacts fertility. In startups, waiting for the perfect market conditions can mean missing the window of opportunity. The key is to act decisively despite the uncertainty.
In both fields, the role of intuition becomes paramount. In my clinic, there are moments when despite all the data, my gut feeling nudges me towards a particular course of action. It might be choosing a specific embryo or deciding to alter a treatment protocol. Similarly, in investing, while I rely on market analysis and forecasts, there are times when a founder’s vision and passion resonate with me beyond the numbers. It’s about complementing data with experience and instinct.
This isn’t a romanticization of gut feelings. Intuition is not infallible and can be prone to biases. However, it is a valuable tool, honed by years of experience. In both IVF and investing, I have made wrong calls, but these instances have been pivotal in my learning journey. They’ve taught me to embrace uncertainty, to see it not as a barrier but as a landscape to navigate.
As I continue to operate in these worlds, I remain convinced that uncertainty is not an enemy to be vanquished but a reality to be embraced. Whether it’s the unpredictable nature of fertility treatment or the volatile startup ecosystem, the common thread is resilience. It’s about learning to dance with uncertainty, making informed decisions, and sometimes, trusting your gut.
For those navigating these uncertain waters, my advice is simple: embrace the journey with all its unpredictability. For couples undergoing IVF, this means finding joy in the small moments and leaning on your support network. For startup founders, it means being open to change and seeing setbacks as stepping stones. In both cases, the potential for profound joy and fulfillment exists, and that is what makes the journey worth every step.
In closing, the parallels between IVF and startups are striking. Both require a robust support system, a willingness to embrace uncertainty, and an ability to find joy in the journey. As someone deeply entrenched in both worlds, I can attest that while the paths may be fraught with challenges, they are also ripe with the possibility of profound reward.